What is included in the FDA catalyst calendar?

Available records include a drug, indication, ticker, event type, development phase, target date, status or outcome context, market information, and a source link.

Does a target date mean an FDA decision is scheduled?

Not always. It may refer to a company milestone, data presentation, trial update, or estimated catalyst. Read the source record to understand the event.

Why can the calendar contain old dates?

Coverage can include historical catalyst records for context. Filter by dates and verify the latest status before treating a record as actionable.

Can this tool predict approval or trial success?

No. It organizes reported events. Clinical evidence, regulatory review, safety, and commercial factors determine outcomes.

What should I verify after finding a catalyst?

Open the source announcement, confirm the drug and indication, check the trial or regulatory document, review the latest company filing, and reassess the date.

Are options and market cap signals of catalyst quality?

No. They provide market context only. They do not measure clinical probability, approval odds, or the expected price reaction.

Finance Agent capability

Track Drug Catalysts Before They Move a Biotech Story

Pineify Finance Agent organizes FDA-related market catalyst records by drug, ticker, indication, development phase, event type, target date, and source coverage. Use the calendar to find biotech events worth researching and to connect a catalyst with the company context, while treating dates and outcomes as reported evidence that must be verified.

Explore FDA catalysts Explore all capabilities

Opens Finance Agent with an FDA catalyst-calendar question ready to send.

Finance Agent FDA calendar cards showing Imetelstat and NUPLAZID catalysts with phase, target date, indication, and source links — Finance Agent FDA-calendar result captured September 14, 2026. The native feed shows 20 catalyst records; the excerpt includes Imetelstat (GERN), a Phase 3 top-line-data event targeted for April 13, 2021, and NUPLAZID (ACAD), a Phase 2b data presentation with a late-October to early-November 2021 target range. The historical dates illustrate why each record must be checked against current primary sources.

A research queue for biotech catalysts

See the drug, indication, phase, and target date together before opening the source

Biotech research is often event-driven. Finance Agent brings drug names, indications, phases, event types, target dates, and source headlines into one scan-friendly calendar so you can decide which catalysts deserve a closer read.

A calendar record is not a guarantee of approval, trial success, or a current event. Dates can be estimates, historical records can remain in coverage, and the source may describe a presentation rather than an FDA decision. Verify the original announcement and latest company disclosure.

Use cases

Ways to use the FDA catalyst calendar

Find catalysts by drug or ticker

Narrow a broad calendar to the medicines, companies, or indications that matter to your research question.

See development context

Keep phase, event type, target date, options availability, and market-cap context together when triaging an event.

Open the source behind the record

Follow source links to confirm what was announced, what remains uncertain, and whether the event is still actionable.

Prompt examples

FDA-calendar questions you can ask Finance Agent

Limits to keep in view

Target dates can be estimates, ranges, or historical records. Confirm the current status and source timestamp before treating an event as upcoming.
A presentation, trial update, or company announcement is not the same as an FDA approval or regulatory decision.
Drug, indication, phase, ticker, and outcome fields depend on provider coverage and may be missing, stale, or inconsistently named.
Market-cap and options flags are context fields, not measures of clinical probability, commercial success, or investment quality.
Calendar records do not replace trial registries, FDA documents, company filings, safety data, or specialist clinical review.
This feature is informational research, not medical, regulatory, or investment advice. Verify primary sources and assess the risks independently.

FAQ

Questions about the FDA catalyst calendar

From catalyst date to evidence-led diligence

Use the calendar to build a watchlist, then read the source announcement, clinical context, regulatory status, and company disclosures before making a decision.

Open Finance Agent

For informational and research use only. No output is investment advice or a guarantee of future performance.